Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 26, 2022

SELL
$12.15 - $35.28 $2.69 Million - $7.81 Million
-221,424 Closed
0 $0
Q4 2021

Jan 26, 2022

SELL
$30.49 - $48.49 $44,088 - $70,116
-1,446 Reduced 0.65%
221,424 $7.56 Million
Q3 2021

Oct 26, 2021

BUY
$41.66 - $52.52 $210,091 - $264,858
5,043 Added 2.32%
222,870 $10.8 Million
Q2 2021

Jul 20, 2021

BUY
$36.62 - $51.69 $327,602 - $462,418
8,946 Added 4.28%
217,827 $9.84 Million
Q1 2021

Apr 30, 2021

SELL
$41.56 - $59.88 $2.19 Million - $3.16 Million
-52,800 Reduced 20.18%
208,881 $10.1 Million
Q4 2020

Jan 27, 2021

SELL
$36.08 - $56.47 $4.09 Million - $6.41 Million
-113,451 Reduced 30.24%
261,681 $14.1 Million
Q3 2020

Oct 26, 2020

SELL
$33.26 - $40.48 $2.66 Million - $3.24 Million
-79,947 Reduced 17.57%
375,132 $13.8 Million
Q2 2020

Jul 23, 2020

BUY
$24.21 - $31.02 $2.85 Million - $3.66 Million
117,882 Added 34.96%
455,079 $14.1 Million
Q1 2020

Apr 16, 2020

SELL
$20.5 - $34.53 $91,163 - $153,554
-4,447 Reduced 1.3%
337,197 $9.32 Million
Q4 2019

Jan 22, 2020

BUY
$18.96 - $29.84 $106,593 - $167,760
5,622 Added 1.67%
341,644 $9.97 Million
Q3 2019

Oct 24, 2019

SELL
$19.12 - $26.24 $106,077 - $145,579
-5,548 Reduced 1.62%
336,022 $6.47 Million
Q2 2019

Jul 19, 2019

SELL
$19.57 - $24.1 $20,724 - $25,521
-1,059 Reduced 0.31%
341,570 $7.49 Million
Q1 2019

Apr 29, 2019

BUY
$12.14 - $20.46 $73,459 - $123,803
6,051 Added 1.8%
342,629 $7 Million
Q4 2018

Jan 28, 2019

BUY
$11.24 - $18.5 $4,900 - $8,066
436 Added 0.13%
336,578 $4.27 Million
Q3 2018

Oct 29, 2018

BUY
$12.5 - $15.38 $4.2 Million - $5.17 Million
336,142 New
336,142 $5.15 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.21B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Norris Perne & French LLP Portfolio

Follow Norris Perne & French LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norris Perne & French LLP, based on Form 13F filings with the SEC.

News

Stay updated on Norris Perne & French LLP with notifications on news.